Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 17, 2014
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: December 18, 2013
Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 26, 2013
Dual-energy x-ray absorptiometry: interpreting reports and serial measurements.
Journal: Clinical obstetrics and gynecology
Published: September 12, 2013
Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial.
Journal: Obstetrics and gynecology
Published: July 02, 2013
Showing 1-5 of 5
Last Updated: 09/26/2026